Latest news with #ISO17100
Yahoo
09-06-2025
- Business
- Yahoo
Sesen Launches with a Singular Mission: Advancing Life Sciences Globally Through Specialized Language Solutions
BOSTON, June 09, 2025--(BUSINESS WIRE)--Today marks the official launch of Sesen, a next-generation language services company purpose-built to meet the complex demands of the life sciences industry. Specializing exclusively in translation, localization, and AI-enhanced linguistic solutions for pharmaceutical, biotechnology, medical device, CRO, and regulatory organizations, Sesen combines industry expertise with cutting-edge technology to deliver fast, accurate, and fully compliant multilingual communications across 150+ languages. Built by industry veterans, Sesen is redefining how life sciences companies manage language workflows, from clinical trial documentation and regulatory labeling to patient communications and digital health platforms. At the core of its offering is SesenGPT, a proprietary AI engine trained on life sciences terminology and optimized for medical and regulatory content. Key Capabilities Include: Regulatory-compliant translations aligned with EMA, FDA, and PMDA guidelines ISO 17100, ISO 9001:2015, and ISO 13485:2016 certified quality management AI-enabled hybrid workflows for clinical trial translations, pharmacovigilance, and labeling Native linguists and MD/PhD medical reviewers for domain-specific accuracy Scalable language solutions integrated with sponsor CMS and eTMF systems "Life sciences innovation is increasingly global, but language remains a critical barrier," said Dr. Vladimir Misik, VP of Global Clinical Trial Strategy. "We launched Sesen to solve this challenge with unmatched specialization, seamless technology integration, and the linguistic precision this industry demands." Diego Di Leva, Sesen's VP of Global Operations, and a certified ISO 9001 and ISO 13485 auditor, added: "At Sesen, language quality is not an afterthought, it's built into the DNA of every project. Our quality assurance framework is grounded in international standards and supported by linguists with deep domain expertise, ensuring every deliverable meets the highest regulatory and scientific expectations." With a growing network of linguists, in-country reviewers, and regulatory consultants, Sesen supports top pharmaceutical and biotechnology companies with on-time, compliant delivery of multilingual assets for product launches, clinical trials, and regulatory submissions. About Sesen Sesen is a specialized language solutions provider exclusively serving the life sciences industry. Focused on clinical, regulatory, and commercial translation, Sesen supports pharmaceutical, biotech, medical device, and CRO clients in 150+ languages. The company combines native linguists, medical professionals, and ISO-certified workflows with proprietary AI technology to deliver faster, more accurate, and compliant content. From clinical trial support to product localization, Sesen enables life sciences organizations to operate with linguistic confidence and regulatory precision. View source version on Contacts Media Contact: Nikki Andrewspress@ Sign in to access your portfolio
Business Wire
09-06-2025
- Business
- Business Wire
Sesen Launches with a Singular Mission: Advancing Life Sciences Globally Through Specialized Language Solutions
BOSTON--(BUSINESS WIRE)--Today marks the official launch of Sesen, a next-generation language services company purpose-built to meet the complex demands of the life sciences industry. Specializing exclusively in translation, localization, and AI-enhanced linguistic solutions for pharmaceutical, biotechnology, medical device, CRO, and regulatory organizations, Sesen combines industry expertise with cutting-edge technology to deliver fast, accurate, and fully compliant multilingual communications across 150+ languages. Built by industry veterans, Sesen is redefining how life sciences companies manage language workflows, from clinical trial documentation and regulatory labeling to patient communications and digital health platforms. At the core of its offering is SesenGPT, a proprietary AI engine trained on life sciences terminology and optimized for medical and regulatory content. Key Capabilities Include: Regulatory-compliant translations aligned with EMA, FDA, and PMDA guidelines ISO 17100, ISO 9001:2015, and ISO 13485:2016 certified quality management AI-enabled hybrid workflows for clinical trial translations, pharmacovigilance, and labeling Native linguists and MD/PhD medical reviewers for domain-specific accuracy Scalable language solutions integrated with sponsor CMS and eTMF systems 'Life sciences innovation is increasingly global, but language remains a critical barrier,' said Dr. Vladimir Misik, VP of Global Clinical Trial Strategy. 'We launched Sesen to solve this challenge with unmatched specialization, seamless technology integration, and the linguistic precision this industry demands.' Diego Di Leva, Sesen's VP of Global Operations, and a certified ISO 9001 and ISO 13485 auditor, added: "At Sesen, language quality is not an afterthought, it's built into the DNA of every project. Our quality assurance framework is grounded in international standards and supported by linguists with deep domain expertise, ensuring every deliverable meets the highest regulatory and scientific expectations." With a growing network of linguists, in-country reviewers, and regulatory consultants, Sesen supports top pharmaceutical and biotechnology companies with on-time, compliant delivery of multilingual assets for product launches, clinical trials, and regulatory submissions. About Sesen Sesen is a specialized language solutions provider exclusively serving the life sciences industry. Focused on clinical, regulatory, and commercial translation, Sesen supports pharmaceutical, biotech, medical device, and CRO clients in 150+ languages. The company combines native linguists, medical professionals, and ISO-certified workflows with proprietary AI technology to deliver faster, more accurate, and compliant content. From clinical trial support to product localization, Sesen enables life sciences organizations to operate with linguistic confidence and regulatory precision.
Yahoo
09-06-2025
- Business
- Yahoo
Sesen Launches with a Singular Mission: Advancing Life Sciences Globally Through Specialized Language Solutions
BOSTON, June 09, 2025--(BUSINESS WIRE)--Today marks the official launch of Sesen, a next-generation language services company purpose-built to meet the complex demands of the life sciences industry. Specializing exclusively in translation, localization, and AI-enhanced linguistic solutions for pharmaceutical, biotechnology, medical device, CRO, and regulatory organizations, Sesen combines industry expertise with cutting-edge technology to deliver fast, accurate, and fully compliant multilingual communications across 150+ languages. Built by industry veterans, Sesen is redefining how life sciences companies manage language workflows, from clinical trial documentation and regulatory labeling to patient communications and digital health platforms. At the core of its offering is SesenGPT, a proprietary AI engine trained on life sciences terminology and optimized for medical and regulatory content. Key Capabilities Include: Regulatory-compliant translations aligned with EMA, FDA, and PMDA guidelines ISO 17100, ISO 9001:2015, and ISO 13485:2016 certified quality management AI-enabled hybrid workflows for clinical trial translations, pharmacovigilance, and labeling Native linguists and MD/PhD medical reviewers for domain-specific accuracy Scalable language solutions integrated with sponsor CMS and eTMF systems "Life sciences innovation is increasingly global, but language remains a critical barrier," said Dr. Vladimir Misik, VP of Global Clinical Trial Strategy. "We launched Sesen to solve this challenge with unmatched specialization, seamless technology integration, and the linguistic precision this industry demands." Diego Di Leva, Sesen's VP of Global Operations, and a certified ISO 9001 and ISO 13485 auditor, added: "At Sesen, language quality is not an afterthought, it's built into the DNA of every project. Our quality assurance framework is grounded in international standards and supported by linguists with deep domain expertise, ensuring every deliverable meets the highest regulatory and scientific expectations." With a growing network of linguists, in-country reviewers, and regulatory consultants, Sesen supports top pharmaceutical and biotechnology companies with on-time, compliant delivery of multilingual assets for product launches, clinical trials, and regulatory submissions. About Sesen Sesen is a specialized language solutions provider exclusively serving the life sciences industry. Focused on clinical, regulatory, and commercial translation, Sesen supports pharmaceutical, biotech, medical device, and CRO clients in 150+ languages. The company combines native linguists, medical professionals, and ISO-certified workflows with proprietary AI technology to deliver faster, more accurate, and compliant content. From clinical trial support to product localization, Sesen enables life sciences organizations to operate with linguistic confidence and regulatory precision. View source version on Contacts Media Contact: Nikki Andrewspress@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
31-03-2025
- Business
- Yahoo
TransPerfect's GlobalLink Named Leader in Enterprise Translation Management in G2 Spring 2025 Report
17 Honors Include Best Support, Easiest to Use & Most Likely to Recommend NEW YORK, March 31, 2025 /PRNewswire/ -- TransPerfect, the world's largest provider of language and AI solutions for global business, today announced that its GlobalLink® platform has been recognized as a leading Enterprise Translation Management Tool and Enterprise Website Translation Tool in the G2 Spring 2025 Report. GlobalLink's recognition comes as a result of user feedback that G2 collects and analyzes. Common themes include praise for the platform's speed, user-friendliness, and exceptional customer support. In the G2 report, GlobalLink received 17 honors across seven categories: Enterprise Leader – Enterprise Translation Management United Kingdom Regional Leader – Translation Management Enterprise EMEA Regional Leader – Enterprise Translation Management Enterprise Europe Regional Leader – Enterprise Translation Management Enterprise Leader – Enterprise Website Translation Tools Best Relationship – Enterprise Translation Management Easiest to Do Business With – Mid-Market Website Translation Tools Best Support – Mid-Market Website Translation Tools Users Most Likely to Recommend – Mid-Market Website Translation Tools Easiest to Use – Mid-Market Website Translation Tools Best Meets Requirements – Mid-Market Website Translation Tools Leader – Translation Management Leader – Website Translation Leader – Mid-Market Translation Management Leader – Software Localization Momentum Leader – Translation Management Leader – Localization GlobalLink is TransPerfect's flagship translation management platform. Its AI-powered localization and content automation solutions make creating, deploying, and managing multilingual content and experiences simple and cost-effective. Over 6,000 global companies rely on GlobalLink to ensure speed, simplicity, and quality anywhere their business goals depend on effective localized content and experiences. TransPerfect President and Co-CEO Phil Shawe remarked, "Customer endorsements are the highest honor we can achieve. Thanks to G2 for amassing and recognizing client feedback on our flagship technology, GlobalLink, in so many categories and use cases." About TransPerfect TransPerfect is the world's largest provider of language services and AI solutions for global business. From offices in over 140 cities on six continents, TransPerfect offers a full range of services in 200+ languages to clients worldwide. More than 6,000 global organizations employ TransPerfect's GlobalLink® technology to simplify the management of multilingual content. With an unparalleled commitment to quality and client service, TransPerfect is fully ISO 9001 and ISO 17100 certified. TransPerfect has global headquarters in New York, with regional headquarters in London and Hong Kong. For more information, please visit our website at About G2 Reports G2 is one of the largest peer-to-peer software review platforms, reaching over 90 million software buyers annually. The platform hosts more than 2.5 million trusted user reviews for over 180,000 software and service companies. G2 Reports are released quarterly and rank software based on verified user reviews, customer satisfaction, and market presence. Learn more at View original content to download multimedia: SOURCE TransPerfect Sign in to access your portfolio
Associated Press
28-03-2025
- Business
- Associated Press
TransPerfect's DataForce Wins 2025 Artificial Intelligence Excellence Award
NEW YORK, March 28, 2025 (GLOBE NEWSWIRE) -- DataForce, TransPerfect's AI data solutions division, today announced that it has been honored as a winner in the Business Intelligence Group's 2025 Artificial Intelligence Excellence Awards. This award, presented in the Natural Language Processing category, highlights DataForce's continued leadership in AI data solutions and its impact in developing safer, more effective AI-driven technologies. DataForce was recognized for its ability to identify and mitigate harmful AI prompts. Observing the need for high-quality, diverse datasets, the team has developed complex content scenarios that address a wide range of risk factors, from implicit to explicit biases. Through a multi-tier annotation process, engaging a diverse global workforce, and iterative dataset refinement, DataForce optimizes models that exceed industry benchmarks in AI safety and effectiveness. The Artificial Intelligence Excellence Awards celebrate companies, technologies, and professionals who are leading the way in AI innovation. Winners are selected by a panel of industry experts who evaluate nominees based on their creativity, impact, and measurable success in AI-driven solutions. TransPerfect President Phil Shawe stated, 'Our DataForce AI team consistently delivers extraordinary client work. This honor would not be possible without their diligence and professionalism.' About DataForce DataForce is a worldwide data collection and labeling platform that combines technology with a diverse network of more than 1 million data contributors, scientists, and engineers. DataForce offers companies in technology, automotive, life sciences, and other industries secure and reliable AI services for exceptional structured data and customer experiences. DataForce is part of the TransPerfect family of companies, the world's largest provider of language and AI solutions for global business with offices in more than 140 cities worldwide. For more information about DataForce and its award-winning AI solutions, please visit About TransPerfect TransPerfect is the world's largest provider of language and AI solutions for global business. From offices in over 140 cities on six continents, TransPerfect offers a full range of services in 200+ languages to clients worldwide. More than 6,000 global organizations employ TransPerfect's GlobalLink ® technology to simplify the management of multilingual content. With an unparalleled commitment to quality and client service, TransPerfect is fully ISO 9001 and ISO 17100 certified. TransPerfect has global headquarters in New York, with regional headquarters in London and Hong Kong. For more information, please visit our website at The Business Intelligence Group was founded with the mission of recognizing true talent and superior performance in the business world. Unlike other industry award programs, these programs are judged by business executives having experience and knowledge. The organization's proprietary and unique scoring system selectively measures performance across multiple business domains and rewards those companies whose achievements stand above those of their peers. For more information, please visit
